What causes vkc

What is Vernal Keratoconjunctivitis (VKC)?

Vernal Keratoconjunctivitis (VKC), often referred to as 'spring catarrh,' is a chronic, recurrent, bilateral inflammatory condition of the conjunctiva and cornea. It is a specific type of allergic eye disease that predominantly affects children and young adults, typically appearing in the first decade of life and often improving or resolving by the early twenties. While it can occur year-round, it is frequently seasonal, worsening during warmer months, hence the name 'vernal' or 'spring.' VKC is characterized by intense itching, foreign body sensation, photophobia (light sensitivity), and a stringy, mucoid discharge.

What Causes VKC?

The exact cause of VKC is not fully understood, but it is widely accepted to be an allergic or hypersensitivity reaction mediated by the immune system. The condition is triggered by exposure to various environmental allergens, particularly those prevalent during warmer seasons. These allergens can include:

• Pollen: From trees, grasses, and weeds.
• Dust mites: Microscopic organisms found in household dust.
• Animal dander: Tiny flakes of skin shed by pets like cats and dogs.
• Mold spores: Fungi found in damp environments.

The immune system of individuals predisposed to VKC overreacts to these otherwise harmless substances. This overreaction involves the release of histamine and other inflammatory mediators, leading to the characteristic symptoms of VKC. Specifically, it is believed to be a Type I hypersensitivity reaction, similar to other allergic conditions like asthma and allergic rhinitis, often involving elevated levels of Immunoglobulin E (IgE) antibodies.

Who is at Risk for VKC?

Certain factors increase the likelihood of developing VKC:

• Age: Most common in children and adolescents, typically between the ages of 3 and 25.
• Sex: Males are more commonly affected than females, with a reported ratio of around 3:1.
• Atopy: A personal or family history of allergic diseases, such as asthma, allergic rhinitis (hay fever), or eczema, is a significant risk factor. Individuals with atopy have a genetically determined tendency to develop allergic reactions.
• Environmental Factors: Living in warmer climates or environments with high concentrations of allergens can contribute. Exposure to sunlight and heat is also thought to exacerbate symptoms.

What are the Symptoms of VKC?

The symptoms of VKC can vary in severity and presentation but typically include:

• Intense itching: Often the most prominent symptom, leading to rubbing of the eyes.
• Redness (Conjunctival injection): The white part of the eye appears red.
• Watery or mucoid discharge: A thick, stringy, white discharge is characteristic.
• Foreign body sensation: Feeling like something is in the eye.
• Photophobia: Sensitivity to light, which can be quite severe.
• Eyelid swelling: The eyelids may appear puffy.
• Blurred vision: Can occur due to discharge or corneal involvement.

VKC can affect different parts of the eye, leading to distinct clinical forms:

• Tarsal conjunctival form: Characterized by large, cobblestone-like papillae on the inner surface of the upper eyelid.
• Limbal conjunctival form: Involves gelatinous, grayish-white nodules or elevations at the limbus (the border between the cornea and sclera), often at the lower aspect.
• Mixed form: A combination of both tarsal and limbal signs.

Corneal involvement can lead to more serious complications, including shield ulcers (a type of corneal ulcer) and plaque formation, which can impair vision.

How is VKC Diagnosed and Treated?

Diagnosis is typically based on the characteristic clinical presentation, patient history (especially allergic history), and a physical examination of the eyes. Slit-lamp biomicroscopy is crucial for identifying the specific signs of VKC, such as giant papillae on the upper tarsal conjunctiva or limbal nodules.

Treatment aims to control inflammation, relieve symptoms, and prevent complications. It often involves a combination of approaches:

• Allergen avoidance: Minimizing exposure to known triggers.
• Lubrication: Artificial tears can help wash away allergens and soothe the eyes.
• Topical Medications:
  • Antihistamines: To block the effects of histamine.
  • Mast cell stabilizers: To prevent the release of inflammatory mediators.
  • Corticosteroids: Potent anti-inflammatory agents, usually used short-term for severe flare-ups due to potential side effects (e.g., increased intraocular pressure, cataracts).
  • Calcineurin inhibitors (e.g., Tacrolimus, Cyclosporine): Non-steroidal options for long-term management, particularly in severe cases.
• Systemic Medications: Rarely needed, but may be considered in very severe cases.
• Surgery: In rare cases, surgical removal of corneal plaques or conjunctival masses may be necessary.

Regular follow-up with an ophthalmologist is essential to monitor the condition, adjust treatment, and manage any potential complications.